Proxima, Laserscope, Medtronic Qualify For Improved Outpatient Payments

Adoption of Proxima Therapeutics' MammoSite high-dose rate brachytherapy catheter for early-stage breast cancer will increase with its placement into a new-technology APC, the firm maintains